Businesses developing innovative skin products have traditionally been limited by testing methodologies that measure changes beneath the skin driven by collagen, melanin and cells. With strict regulatory attention on product safety and the need for science-backed efficacy claims for consumer trust, how can companies compete in a crowded market?
Testing methods for skin aging and discoloration have traditionally relied on preclinical approaches such as in vitro assays (enzyme inhibition, cell cultures) and skin explants. However, these often fail to translate findings into meaningful real-world results.
This webinar will examine advanced clinical capabilities and instrumentation that enable in vivo testing of the critical biological hallmarks of skin change. The session will provide an up-close look at these methods and include compelling comparisons between baseline and post-treatment findings. Attendees will gain a clear understanding of cutting-edge clinical methodologies, including multispectral imaging, optical biopsy imaging, histochemical imaging on punch biopsy and quantitative polymerase chain reaction (qPCR) on microbiopsy. The webinar will also show how data from these methods can be used to support efficacy claims.
Register today to explore this rapidly evolving area of skin science and gain insights to enhance product claims and differentiate your offerings in a competitive market.
Agenda
- Introduction
- Clinical methods and case study examples
- Q&A
Who should attend?
This webinar will be of interest to brands and ingredient suppliers conducting cosmetic and dermatology research and development.
This webinar takes place June 24, 2026, at 10am (Eastern Daylight Time).
